OCRA is proud to announce the first three recipients of the $6 million we have awarded to support groundbreaking ovarian and related gynecologic cancer research in 2025. And we’re not stopping there—stay tuned as we continue to expand our investment in research this year. This is the first in a multi-part series introducing our newest … Continued
Join us Wednesday, April 9, 2025, for a FREE online seminar to learn about the importance of genetics and biomarkers on the treatment of endometrial cancer. This comprehensive program will cover essential topics including the difference between genetics and biomarkers, what tests are most effective in understanding treatment options, which testing is needed at diagnosis vs. recurrence, … Continued
In a new article from TheaterMania, ovarian cancer survivor and OCRA Advocate Leader Kristen Jantonio shares how her passion for theater has been a source of strength and inspiration since being diagnosed with ovarian cancer. Through OCRA’s Advocate Leader program, she helps drive policy changes that support the gynecologic cancer community. Learn more in Playhouse Square’s Kristen … Continued
Ovarian Cancer Research Alliance (OCRA), the largest global organization dedicated to advancing ovarian and related gynecologic cancer research, announced today the recipients of two prizes awarded for noteworthy work in the field of ovarian cancer research. One honoree received the 2024 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research in recognition of his groundbreaking … Continued
Recent data from the American Cancer Society’s Cancer Facts & Figures 2025 report, also covered by NPR, reveals that cancer diagnoses among younger women are increasing, with cancer incidence rates for women under 50 now 82% higher than those for men in the same age group. For more information, read “Cancer Incidence Rate for Women … Continued
OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective April 1, 2025. This historic collaboration unites two respected organizations committed to advancing research for a cure for ovarian and all gynecologic cancers. “OCRA has always … Continued
OCRA to Expand its Research Initiatives by Integrating Rivkin Center’s Legacy Efforts, Effective April 2025 NEW YORK, NY, January 28, 2025 – Ovarian Cancer Research Alliance (OCRA), the world’s largest gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research will combine with OCRA, effective April 1, 2025. This historic collaboration … Continued
In a new interview with journalist Marcel Clarke for Clarke’s Closer Look, OCRA grantee Dr. Daniel Heller of Memorial Sloan Kettering Cancer Center discusses how his lab is utilizing artificial intelligence (AI) to develop a cutting-edge blood test to detect ovarian cancer at its earliest stages. This OCRA-funded study is in partnership with Microsoft AI … Continued
In a new interview with journalist Marcel Clarke, OCRA’s Chief Program Officer, Sarah DeFeo, discusses the importance of ovarian cancer risk awareness and prevention. The interview appears on Clarke’s Closer Look.
[New York, NY – January 15, 2025] – Ovarian Cancer Research Alliance (OCRA) proudly announces the extraordinary success of its 2024 year-end fundraising campaign, surpassing its $2 million goal and marking a transformative milestone in its mission to eradicate ovarian and related gynecologic cancers. Fueled by the generosity and unwavering support of donors, this achievement … Continued
A Year of Progress: Advances in the Fight Against Ovarian and All Gynecologic Cancers This year, your support enabled Ovarian Cancer Research Alliance (OCRA) to make incredible strides in research, advocacy, and patient support for those facing ovarian and all gynecologic cancers. With your help, we expanded our support programs, fostered critical collaborations, and continued … Continued
OCRA-funded research using artificial intelligence (AI) for ovarian cancer early detection was highlighted in the BBC’s six-part series on how AI is transforming medicine. Dr. Daniel Heller, an OCRA-funded researcher at Memorial Sloan Kettering Cancer Center, shared how his team is using AI and nanotechnology to develop a cutting-edge blood test for early ovarian cancer … Continued
Get email updates about research news, action alerts, and ways to join the fight.
